Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477147 · ClinicalTrials.gov registry record · NA
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
A NA study, sponsored by Volta Medical.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT05477147 is a NA study that has completed, run by Volta Medical. The registered enrollment target is 96 participants.
The verdict
NCT05477147, a NA study, has completed, sponsored by Volta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
Interventions
- DEVICE Catheter Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05477147
The ClinicalTrials.gov registry entry for NCT05477147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volta Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT05477147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05477147 about?
NCT05477147 is a clinical study titled "Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion". Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
What is the current status of trial NCT05477147?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2023-03-17. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05477147?
The interventions under investigation include: Catheter Ablation (DEVICE).
Who is sponsoring clinical trial NCT05477147?
This trial is sponsored by Volta Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.